CSPC Pharmaceutical Group (CSPCY) Stock Price, News & Analysis

Company Overview

CSPC Pharmaceutical Group is a China-based pharmaceutical company headquartered in Shijiazhuang, Hebei. Its business spans the research and development, manufacturing, and sale of medicines and pharmaceutical ingredients.

The company produces innovative and generic finished drugs, as well as bulk pharmaceutical products such as vitamin C. Its medicines address a range of therapeutic areas, including oncology, cardiovascular disease, infections, and disorders of the central nervous system.

CSPC serves customers in China and international markets. The group is led by chairman Cai Dongchen.

Key Stats

• Today's Range: C$4.15 to C$4.15
• 50-Day Range: C$3.94 to C$5.21
• 52-Week Range: C$3.26 to C$5.46
• Volume: 1,437 shs
• Average Volume: 2,951 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:CSPCY
• CIK: N/A
• Web: www.cspc.com.hk
• Phone: 86-31-1870-37015
• Fax: N/A
• Employees: 19,700
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A